EXACT Sciences Newswire

EXACT Sciences Newswire

Comprehensive Real-Time News Feed for EXACT Sciences.

Results 1 - 20 of 587 in EXACT Sciences

  1. Exact Sciences Corporation (EXAS) Downgraded by Vetr Inc. to "Hold"Read the original story w/Photo

    19 min ago | IntersportsWire

    ... on EXAS. Cowen and Company restated an outperform rating and set a $30.00 price objective on shares of Exact Sciences Corporation in a research report on Tuesday, April 4th. Canaccord Genuity increased their price target on Exact Sciences ...

    Comment?

  2. Teacher Retirement System of Texas Takes Position in Exact Sciences CorporationRead the original story w/Photo

    7 hrs ago | IntersportsWire

    Teacher Retirement System of Texas purchased a new position in shares of Exact Sciences Corporation during the first quarter, according to its most recent disclosure with the SEC. The fund purchased 8,593 shares of the medical research company's stock, valued at approximately $203,000.

    Comment?

  3. Exact Sciences Corporation (NASDAQ:EXAS) Expected to Earn Q3 2018 Earnings of ($0.32) Per ShareRead the original story w/Photo

    16 hrs ago | IntersportsWire

    Exact Sciences Corporation - Equities researchers at Craig Hallum issued their Q3 2018 earnings estimates for Exact Sciences Corporation in a note issued to investors on Thursday. Craig Hallum analyst B. Bonello anticipates that the medical research company will earn per share for the quarter.

    Comment?

  4. Point72 Asset Management L.P. Raises Stake in Exact Sciences CorporationRead the original story w/Photo

    Yesterday | IntersportsWire

    Point72 Asset Management L.P. raised its position in Exact Sciences Corporation by 1,534.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,500,476 shares of the medical research company's stock after buying an additional 2,347,476 shares during the period.

    Comment?

  5. Exact Sciences Corporation (EXAS) Receives Consensus Recommendation...Read the original story w/Photo

    Tuesday | AmericanBankingNews.com

    Shares of Exact Sciences Corporation have been given an average recommendation of "Buy" by the eighteen research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eleven have given a buy recommendation to the company.

    Comment?

  6. Exact Sciences Corporation (NASDAQ:EXAS) Lowered to Sell at Vetr Inc.Read the original story w/Photo

    Tuesday | IntersportsWire

    ... commented on EXAS. Cowen and Company reissued an outperform rating and set a $30.00 target price on shares of Exact Sciences Corporation in a research note on Tuesday, April 4th. Canaccord Genuity boosted their target price on Exact Sciences ...

    Comment?

  7. Exact Sciences Corporation (NASDAQ:EXAS) Set to Announce Quarterly Earnings on TuesdayRead the original story w/Photo

    Tuesday | Daily Political

    Exact Sciences Corporation is scheduled to release its earnings data before the market opens on Tuesday, July 25th. Analysts expect Exact Sciences Corporation to post earnings of per share for the quarter.

    Comment?

  8. Exact Sciences Corporation (NASDAQ:EXAS) PT Set at $50.00 by Benchmark Co.Read the original story w/Photo

    Thursday Jul 13 | IntersportsWire

    ... research analysts also recently weighed in on the company. Craig Hallum raised their price objective on Exact Sciences Corporation from $35.00 to $41.00 in a research report on Friday, July 7th. Vetr downgraded Exact Sciences Corporation from a buy ...

    Comment?

  9. Exact Sciences Corporation (EXAS) - Investment Analysts' Recent Ratings ChangesRead the original story w/Photo

    Thursday Jul 13 | AmericanBankingNews.com

    They now have a $34.70 price target on the stock. 7/7/2017 - Exact Sciences Corporation had its price target raised by analysts at Craig Hallum from $35.00 to $41.00.

    Comment?

  10. Craig Hallum Raises Exact Sciences Corporation (EXAS) Price Target to $41.00Read the original story w/Photo

    Wednesday Jul 12 | Daily Political

    Several other brokerages also recently commented on EXAS. Roth Capital reiterated a buy rating and set a $40.00 target price on shares of Exact Sciences Corporation in a research note on Thursday, June 1st.

    Comment?

  11. Vetr Inc. Downgrades Exact Sciences Corporation (NASDAQ:EXAS) to HoldRead the original story w/Photo

    Thursday Jul 6 | AmericanBankingNews.com

    ... Capital restated a "buy" rating and set a $40.00 price objective (up previously from $33.00) on shares of Exact Sciences Corporation in a research note on Thursday, June 1st. ValuEngine upgraded Exact Sciences Corporation from a "sell" rating to a ...

    Comment?

  12. Exact Sciences Corporation (EXAS) vs. Icon Plc (ICLR) Head to Head SurveyRead the original story w/Photo

    Thursday Jul 6 | IntersportsWire

    Icon Plc and Exact Sciences Corporation are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitabiliy, analyst recommendations and institutional ownership. 92.8% of Icon Plc shares are held by institutional investors.

    Comment?

  13. Exact Sciences Corporation (NASDAQ:EXAS) Receives Daily Media Sentiment Score of 0.31Read the original story w/Photo

    Thursday Jul 6 | IntersportsWire

    Media coverage about Exact Sciences Corporation has been trending positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources.

    Comment?

  14. Smaller Device Makers Stay Serene In '17Read the original story w/Photo

    Thursday Jul 6 | Seeking Alpha

    The awesome power wielded by the payers is exemplified by the impressive performance of Exact Sciences shares over the last six months. Shares in the maker of the colorectal cancer stool test Cologuard have soared in value, adding nearly $3bn to its market cap, thanks to a 180-degree reversal in US reimbursement decisions.

    Comment?

  15. Gotham Asset Management LLC Buys New Position in Exact Sciences CorporationRead the original story w/Photo

    Thursday Jul 6 | IntersportsWire

    Gotham Asset Management LLC bought a new stake in Exact Sciences Corporation during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund bought 56,048 shares of the medical research company's stock, valued at approximately $1,324,000.

    Comment?

  16. Vetr Inc. Lowers Exact Sciences Corporation (EXAS) to HoldRead the original story w/Photo

    Tuesday Jul 4 | IntersportsWire

    ... on the stock. Cowen and Company reiterated an outperform rating and issued a $30.00 target price on shares of Exact Sciences Corporation in a report on Tuesday, April 4th. Canaccord Genuity raised their price target on shares of Exact Sciences ...

    Comment?

  17. -$0.37 EPS Expected for EXACT Sciences Co. (EXAS) This QuarterRead the original story w/Photo

    Monday Jul 3 | IntersportsWire

    Equities research analysts expect EXACT Sciences Co. to post earnings of per share for the current quarter, Zacks Investment Research reports.

    Comment?

  18. Exact Sciences Corporation (NASDAQ:EXAS) Lifted to "Buy" at Zacks Investment ResearchRead the original story w/Photo

    Monday Jul 3 | IntersportsWire

    The firm currently has $39.00 price objective on the medical research company's stock. According to Zacks, "EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer.

    Comment?

  19. Exact Sciences Corporation (EXAS) Cut to Hold at Vetr Inc.Read the original story w/Photo

    Monday Jul 3 | Daily Political

    ... reports about the stock. Jefferies Group LLC restated a buy rating and set a $25.00 target price on shares of Exact Sciences Corporation in a research report on Wednesday, April 26th. Leerink Swann set a $38.00 target price on shares of Exact ...

    Comment?

  20. Point72 Asset Management L.P. Boosts Stake in Exact Sciences CorporationRead the original story w/Photo

    Sunday Jul 2 | IntersportsWire

    Point72 Asset Management L.P. raised its stake in shares of Exact Sciences Corporation by 1,534.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 2,500,476 shares of the medical research company's stock after buying an additional 2,347,476 shares during the period.

    Comment?